April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Mifepristone and Photoreceptor Survival
Author Affiliations & Notes
  • Marisa A. Cubilla
    Cell and Molecular Medicine, Ciencias Biomedicas Univ Austral, Pilar, Argentina
  • Mauricio M. Castañeda
    Cell and Molecular Medicine, Ciencias Biomedicas Univ Austral, Pilar, Argentina
  • Maximiliano Olivera
    Cell and Molecular Medicine, Ciencias Biomedicas Univ Austral, Pilar, Argentina
  • Tomas Bachor
    Cell and Molecular Medicine, Ciencias Biomedicas Univ Austral, Pilar, Argentina
  • Angela M. Suburo
    Cell and Molecular Medicine, Ciencias Biomedicas Univ Austral, Pilar, Argentina
  • Footnotes
    Commercial Relationships  Marisa A. Cubilla, None; Mauricio M. Castañeda, None; Maximiliano Olivera, None; Tomas Bachor, None; Angela M. Suburo, None
  • Footnotes
    Support  PICTO 2008-00090
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5462. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marisa A. Cubilla, Mauricio M. Castañeda, Maximiliano Olivera, Tomas Bachor, Angela M. Suburo; Mifepristone and Photoreceptor Survival. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5462.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glucocorticoids (GCs) secreted from the adrenal cortex easily pass through the blood brain barrier and bind to intracellular glucocorticoid (GRα) receptors in neurons and glia. They are critical for survival and viability of neurons and can prevent, or ameliorate, light-induced and inherited retinal degeneration. GRα antagonists, such as mifepristone (MFP or RU-486), have been advocated for treatment of serous chorioretinopathy. We have previously shown that MFP aggravates light-induced retinal degeneration, therefore, we have now studied effects of this GRα antagonist under standard illumination conditions.

Methods: : Balb-c male mice were bred and cared in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Standard illumination conditions are < 60 lux, cyclic 12 h/day. Animals were left in complete darkness during 24 hours and randomly separated into experimental groups receiving: MFP (4, 10 or 30 mg/kg), dexamethasone (DEX, 4 or 10 mg/kg), MFP + DEX, or vehicle alone (VHC). Mice were euthanatized after 6 hours. Retinas were processed for Fragment End Labeling (FragEL) of DNA, immunohistochemistry or Western blots using antibodies against GRα, glutamine synthase (GS), glial fibrillary acidic protein (GFAP), Bcl-XL, Bcl-2 and cleaved caspase-3 (CC-3).

Results: : Within 6 hours, MFP increased GRα in all retinal nuclear layers. A subpopulation of strongly immunoreactive nuclei showed in the INL. Müller cells displayed stronger GS immunoreactivity, but no GFAP. FragEL showed numerous apoptotic nuclei that were exclusively localized in the ONL. Control retinas contained high levels of Bcl-XL, whereas Bcl-2 was undetectable. MFP depleted Bcl-XL and induced Bcl-2 expression. CC-3 was not detected in control retinas but high levels appeared after MFP. Simultaneous treatment with DEX partially reduced CC-3 protein but had no effect on Bcl-XL and Bcl-2.

Conclusions: : MFP induced cell death in photoreceptors, most likely executed by activation of caspase-3. DEX blocked photoreceptor death, indicating that endogenous glucocorticoids would be essential for photoreceptor survival. However, DEX did not completely reverse MFP effects, suggesting that the progesterone receptor might also be involved in photoreceptor survival.

Keywords: apoptosis/cell death • corticosteroids • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×